logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 [see all tables in this series...]

Part (vi) Percentage distribution of new inpatient clients by primary drug for each age group

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opioids015.945.256.65046.943.91930785
Cocaine02.54.15.58.875.61.93660
Stimulants2.22118.811.99.513.19.49106514
Hypnotics and sedatives6.76.258.6172026.753.21024151
Hallucinogens3.31.10.50.30.1000310
Volatile substances23.310.43.41.90.60.80.60.92544
Cannabis 33.335.621.613.211.29.37.85.813060
Other substances 31.17.41.522.836.110.23052
Total9011641842172310236593605687429176

Notes:

 The countries supplying data are: 

 BG, CZ, DK, IE, GR, CY, HU, AT, RO, SK, FI, SE, UK, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008